Fuhrman Alan - Insider Non-Derivative Transactions at Esperion Therapeutics, Inc. (ESPR) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 23, 2024, Fuhrman Alan's relationship to Esperion Therapeutics, Inc. (ESPR) is Director, and currently has 53,404 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ESPR insiders.

Data Source: SEC.
Fuhrman Alan - Insider Non-Derivative Transactions of ESPR Common Stock
Fuhrman Alan - Insider Non-Derivative Transactions at ESPR
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
May 24, 2024 Acquisition -- (Common Stock) 23000 0 53404
Jun 16, 2023 Acquisition -- (Common Stock) 5150 0 30404